心脏术后急性肾损伤早期生物学标志物的研究进展  

Research progress on early biomarkers for acute kidney injury after cardiac surgery

作　　者：吴晓云(综述) 臧旺福(审校)[1] WU Xiaoyun;ZANG Wangfu(Department of Cardiac Surgery,Shanghai Tenth People's Hospital affiliated to Tongji University,Shanghai 200072,China)

机构地区：[1]同济大学附属上海市第十人民医院心脏外科,上海200072

出　　处：《国际检验医学杂志》2022年第1期102-106,共5页International Journal of Laboratory Medicine

基　　金：上海市卫生和计划生育委员会科研课题项目(201740243).

摘　　要：急性肾损伤(AKI)是心脏手术以及其他外科手术后常见且严重的并发症,具有较高的发病率和病死率,目前公认的最佳的治疗措施是早期发现、早期诊断。为此研究者们对AKI早期生物学标志物进行了广泛的研究。该文就几种新型标志物的生物学功能、研究现状、应用前景进行综述。Acute kidney injury(AKI)is a common and serious complication after cardiac surgery and other surgical procedures,with high morbidity and mortality rates.At present,it′s recognized that the best treatment for AKI is early detection and early diagnosis.For this reason,researchers have conducted extensive research on early biomarkers of AKI.This article reviews the biological functions,research status and application prospects of several new biomarkers.

关 键 词：急性肾损伤 心脏术后 生物学标志物 

分 类 号：R69[医药卫生—泌尿科学] R654.2[医药卫生—外科学]